A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies. The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year